Prevalence of Feline Leukaemia Virus and Feline Immunodeficiency Virus Infection in Thailand
World Small Animal Veterinary Association World Congress Proceedings, 2003
A. Litster1; P. Nilkumhang2
1School of Veterinary Science, University of Queensland, Brisbane, Australia; 2Department of Veterinary Medicine, Faculty of Veterinary Medicine, Kasetsart University, Bangkok, Thailand

Objectives

To determine the prevalence of Feline Leukaemia Virus (FeLV) and Feline Immunodeficiency Virus (FIV) infection in cats presented to veterinary hospitals and animal shelters in the Bangkok area.

Materials & Methods

One hundred and fifteen cats were examined and age, sex, breed and recent clinical information were recorded. Cats were clinically categorised as sick or healthy. Sera were collected and blindly and independently tested for FeLV antigen and FIV antibodies using AGEN Vetmail (AGEN Biomedical, Acacia Ridge, Q., Australia).

Results

There were 38 healthy and 77 sick cats. None of the healthy cats tested positive for FeLV or FIV. Five (6%) sick cats tested positive for FeLV antigen and another four (5%) were positive for FIV antibodies.

Conclusion

Based on serological data, there is a low prevalence of feline retroviral infection in the Bangkok area.

Merial, Thailand and AGEN Biomedical, Australia provided funding for this project.

Speaker Information
(click the speaker's name to view other papers and abstracts submitted by this speaker)

A. Litster
School of Veterinary Science
University of Queensland
Brisbane, Australia


MAIN : Oral Presentations : FeLV/FIV in Thailand
Powered By VIN

Friendly Reminder to Our Colleagues: Use of VIN content is limited to personal reference by VIN members. No portion of any VIN content may be copied or distributed without the expressed written permission of VIN.

Clinicians are reminded that you are ultimately responsible for the care of your patients. Any content that concerns treatment of your cases should be deemed recommendations by colleagues for you to consider in your case management decisions. Dosages should be confirmed prior to dispensing medications unfamiliar to you. To better understand the origins and logic behind these policies, and to discuss them with your colleagues, click here.

Images posted by VIN community members and displayed via VIN should not be considered of diagnostic quality and the ultimate interpretation of the images lies with the attending clinician. Suggestions, discussions and interpretation related to posted images are only that -- suggestions and recommendations which may be based upon less than diagnostic quality information.

CONTACT US

777 W. Covell Blvd., Davis, CA 95616

vingram@vin.com

PHONE

  • Toll Free: 800-700-4636
  • From UK: 01-45-222-6154
  • From anywhere: (1)-530-756-4881
  • From Australia: 02-6145-2357
SAID=27